Relationship between Apoptosis Imaging and Radioiodine Therapy in Tumor Cells with Different Sodium Iodide Symporter Gene Expression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Kyung Oh | - |
dc.contributor.author | Youn, Hyewon | - |
dc.contributor.author | Kim, Young-Hwa | - |
dc.contributor.author | Kim, Seunghoo | - |
dc.contributor.author | Na, Juri | - |
dc.contributor.author | Kim, Yong-il | - |
dc.contributor.author | Park, Jin Woo | - |
dc.contributor.author | Kang, Keon Wook | - |
dc.contributor.author | Lee, Dong Soo | - |
dc.contributor.author | Chung, June-Key | - |
dc.date.accessioned | 2024-01-09T14:10:07Z | - |
dc.date.available | 2024-01-09T14:10:07Z | - |
dc.date.issued | 2015-03 | - |
dc.identifier.issn | 1535-3508 | - |
dc.identifier.issn | 1536-0121 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/70384 | - |
dc.description.abstract | The therapeutic efficacy of radioiodine (I-131) therapy has been reported to be variable among cancer patients and even between metastatic regions in the same patients. Because the expression level of sodium iodide symporter (NIS) cannot reflect the efficacy of therapy, other strategies are required to predict the precise therapeutic effect of I-131 therapy. In this research, we investigated the correlation between iodine (I) uptake, apoptosis imaging, and therapeutic efficacy. Two HT29 cell lines, cytomegalovirus (CMV)-NIS (or NIS+++) and TERT-NIS (or NIS+), were established by retroviral transfection. I uptake was estimated by I-uptake assay and gamma camera imaging. Apoptosis was evaluated by confocal microscopy and a Maestro fluorescence imaging system (CRi Inc., Woburn, MA) using ApoFlamma (BioACTs, Seoul, Korea), a fluorescent dye-conjugated apoptosis-targeting peptide 1 (ApoPep-1). Therapeutic efficacy was determined by tumor size. The CMV-NIS showed higher I uptake and ApoFlamma signals than TERT-NIS. In xenograft models, CMV-NIS also showed high 99m technetium signals and ApoFlamma signals. Tumor reduction had a stronger correlation with apoptosis imaging signals than with gamma camera imaging signals, which reflect I uptake. Higher NIS-expressing tumors showed increased apoptosis and I uptake, resulting in a significant tumor reduction. Moreover, tumor reduction showed a strong correlation with ApoFlamma imaging compared to I-uptake imaging. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SAGE PUBLICATIONS INC | - |
dc.title | Relationship between Apoptosis Imaging and Radioiodine Therapy in Tumor Cells with Different Sodium Iodide Symporter Gene Expression | - |
dc.type | Article | - |
dc.identifier.doi | 10.2310/7290.2014.00050 | - |
dc.identifier.bibliographicCitation | MOLECULAR IMAGING, v.14 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000351643500012 | - |
dc.identifier.scopusid | 2-s2.0-84945255208 | - |
dc.citation.title | MOLECULAR IMAGING | - |
dc.citation.volume | 14 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordPlus | THYROID-CARCINOMA | - |
dc.subject.keywordPlus | PEPTIDE | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | DEATH | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.